addextherapeutics.com (ADXN) - Earnings per share increase in current year
Swiss biotech Addex Therapeutics (ADXN) minimizes risks through a diversified pipeline and neutral geopolitical status. The percentage dynamics of earnings per share over the year visualize these successes, where the 0.00 indicator expresses the current state of the metric. However, intense competition with global behemoths in the field of neuroscience creates serious challenges for the company's long-term dominance.
Analytical breakdowns and data insights for company Addex Therapeutics (ADXN)
- stock quotes and analyst forecast:
- market capitalization indicators:
- business book valuation details:
- debt and solvency information:
Debt to Capital Addex Therapeutics|ADXN - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital addextherapeutics.com|ADXN - Company Aggregate Debts|Debts to Book Capitalization Addex|ADXN - Company Long-Term Debt|Current Liabilities Addex Therapeutics|Immediate Liquidity addextherapeutics.com
- earnings and valuation multiples indicators:
ADXN - Net Income|Projected Future Earnings Addex Therapeutics|ADXN - Price to Earnings Ratio|Market Cap to Future Earnings Ratio Addex|ADXN - PEG Multiple|Total Company Value to Operating Income Before Depreciation Ratio Addex|ADXN - Operating profit EBITDA|Net earnings per share for the last 12 months Addex Therapeutics|ADXN - Earnings per share for the last twelve months|Year-over-year net earnings per share change for the last twelve months addextherapeutics.com|ADXN - Earnings growth in current year|Earnings growth forecast for next year Addex Therapeutics
Fundamental valuation:Addex Therapeutics
Stable neuro-portfolio management and international partnerships at Addex Therapeutics (ADXN) establish a foundation for long-term capitalization. By analyzing year-over-year earnings per share (EPS) growth, investors can track net income dynamics stripped of seasonal fluctuations through annual comparison. Extreme deviations in this metric signal a shift in the growth phase, allowing for a timely assessment of the biotech's business model sustainability.
Main competitors
Earnings per share growth this year BIIB|Net earnings per share growth this year NBIX|RGC: Earnings per share increase in current year|Net earnings per share growth this year AXSM (Axsome Therapeutics)|Net earnings per one share growth for the current year ACAD|Earnings growth in current year XENE (Xenon)|Earnings per share increase in current year VKTX|Supernus Pharma - Earnings growth in current year|Earnings per share growth rate in current year Catalyst Corp|Denali Therapeutics (DNLI) - Earnings per share growth in current year|harmonybiosciences.com - Earnings per share increase in current year|BHVN (Biohaven) - Earnings growth in current year|Earnings growth in current year Amylyx Pharmaceuticals Inc|Earnings per share growth in current year Trevi Pharma (TRVI)|PRAX: Earnings per share trend in current year|Earnings growth in current year AVXL (Anavex Life Sciences)|ceribell.com (CBLL) - Earnings per share growth rate in current year|PRTA: Net earnings per share growth this year|ALEC - Earnings growth in current year|ANNX (Annexon Inc.) - Net earnings per share growth this year|OMER: Net earnings per one share growth for the current year|NGNE (Neurogene Inc.) - Earnings growth in current year|acimmune.com (ACIU) - Expected net earnings per share growth this year|Earnings growth in current year VYGR|Net earnings per share growth this year Neumora NMRA|Earnings per share growth in current year Scilex Holding Co. SCLX|Expected net earnings per share growth this year Tevogen Bio Inc. (TVGN)|Alpha Cognition Corp - Earnings growth in current year|CGTX - Earnings growth in current year|IKT: Earnings growth in current year|Earnings per share growth this year SAVA|Net earnings per share growth this year ASRT|Earnings per share growth this year COYA (Coya)|Earnings per share growth in current year Vistagen Therapeutics (VTGN)|ovidrx.com - Earnings per share growth this year|Earnings per share growth in current year Acumen Pharmaceuticals, Inc. ABOS|CRVO: Earnings per share growth this year|Alterity Therapeutics Ltd - Earnings growth in current year|Earnings per share growth rate in current year Clene Inc.|PEPG (pepgen.com) - Net earnings per share growth this year|Jupiter Neurosciences, Inc. (JUNS) - Earnings growth in current year|Earnings per share growth in current year Relmada Therapeutics, Inc.|ANVS: Earnings per share increase in current year|Earnings per share growth in current year Grace Therapeutics, Inc. (GRCE)|AIFF - Earnings per share growth rate in current year|Earnings growth in current year KLTO (Klotho Neurosciences)|Earnings growth in current year NeuroSense Therapeutics Ltd NRSN|Reviva Pharmaceuticals Holdings, Inc. - Earnings growth in current year|MTVA (MetaVia Inc) - Earnings per share growth this year|NRXS: Earnings growth in current year|Earnings per share growth this year HSDT|PASG (Passage Bio Inc.) - Earnings growth in current year|Earnings per share growth rate in current year Neuphoria NEUP|Net earnings per share growth this year NERV (Minerva Neurosciences, Inc.)|Athira Pharma Inc - Earnings per share growth this year|Alzamend Neuro - Net earnings per share growth this year|Earnings per share increase in current year CYCN|PTIX: Net earnings per share growth this year|Pasithea Therapeutics - Net earnings per one share growth for the current year|CRGT: Earnings growth in current year|Avenue Therapeutics Inc. - Earnings per share increase in current year|BCLI (Brainstorm Cell Therapeutics, Inc.) - Earnings growth in current year|Earnings per share growth rate in current year Cara Therapeutics Inc CARA|Earnings per share growth in current year Chromocell Therapeutics (CHRO)|ELYM (eliemtx.com) - Earnings per share increase in current year|Earnings growth in current year ITCI (Intra-Cellular Therapies, Inc.)|Earnings growth in current year Longboard Pharmaceuticals Inc LBPH|MRNS - Earnings per share growth in current year|Earnings per share trend in current year NKGN|NRBO: Earnings growth in current year|Earnings per share growth rate in current year sagerx.com (SAGE)|Net earnings per share growth this year SNPX|Earnings growth in current year Trevena Inc.|Net earnings per share growth this year VIGL (Vigil Neuroscience)|Net earnings per one share growth for the current year WENA|Earnings growth in current year CERE (Cerevel Therapeutics)
